Aceragen | Capital De Empréstimo



Capital De Empréstimo Alterar Data
Abbott USD 11.6B 1.33B 2025-09
Agenus USD 23.6M 448K 2025-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Alterity Therapeutics Limited AUD 103.21K 73.88K 2023-06
Amgen USD 50B 2.43B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.69B 1.37B 2025-06
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 10.67B 564.4M 2025-09
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Pfizer USD 57.41B 93M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
X T L Biopharmaceuticals USD 0 0 2024-12


Aceragen Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.